Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
HURC vs AME vs DHR vs MKSI vs A
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Medical - Diagnostics & Research
Hardware, Equipment & Parts
Medical - Diagnostics & Research
HURC vs AME vs DHR vs MKSI vs A — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Medical - Diagnostics & Research | Hardware, Equipment & Parts | Medical - Diagnostics & Research |
| Market Cap | $107M | $53.72B | $124.33B | $20.25B | $33.58B |
| Revenue (TTM) | $132M | $7.60B | $24.78B | $4.07B | $7.07B |
| Net Income (TTM) | $-14M | $1.53B | $3.69B | $327M | $1.29B |
| Gross Margin | 24.9% | 36.6% | 60.7% | 45.2% | 38.8% |
| Operating Margin | -8.6% | 26.2% | 21.0% | 14.8% | 20.6% |
| Forward P/E | 7.6x | 29.1x | 20.8x | 30.4x | 19.9x |
| Total Debt | $12M | $2.28B | $18.42B | $4.69B | $3.35B |
| Cash & Equiv. | $49M | $458M | $4.62B | $675M | $1.79B |
HURC vs AME vs DHR vs MKSI vs A — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Hurco Companies, In… (HURC) | 100 | 53.3 | -46.7% |
| AMETEK, Inc. (AME) | 100 | 255.7 | +155.7% |
| Danaher Corporation (DHR) | 100 | 118.9 | +18.9% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| Agilent Technologie… (A) | 100 | 134.6 | +34.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HURC vs AME vs DHR vs MKSI vs A
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HURC has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.
- Lower volatility, beta 0.86, Low D/E 6.0%, current ratio 4.33x
- Beta 0.86, current ratio 4.33x
- Lower P/E (7.6x vs 30.4x)
- Beta 0.86 vs MKSI's 2.64, lower leverage
AME is the #2 pick in this set and the best alternative if quality and dividends is your priority.
- 20.1% margin vs HURC's -10.8%
- 0.5% yield, 16-year raise streak, vs A's 0.8%, (1 stock pays no dividend)
Among these 5 stocks, DHR doesn't own a clear edge in any measured category.
MKSI ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 9.6%, EPS growth 55.5%, 3Y rev CAGR 3.5%
- 7.5% 10Y total return vs AME's 423.4%
- 9.6% revenue growth vs HURC's -4.3%
- +306.1% vs DHR's -8.3%
A is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 10 yrs, beta 1.23, yield 0.8%
- PEG 1.35 vs DHR's 34.35
- 10.1% ROA vs HURC's -5.4%, ROIC 13.5% vs -4.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.6% revenue growth vs HURC's -4.3% | |
| Value | Lower P/E (7.6x vs 30.4x) | |
| Quality / Margins | 20.1% margin vs HURC's -10.8% | |
| Stability / Safety | Beta 0.86 vs MKSI's 2.64, lower leverage | |
| Dividends | 0.5% yield, 16-year raise streak, vs A's 0.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +306.1% vs DHR's -8.3% | |
| Efficiency (ROA) | 10.1% ROA vs HURC's -5.4%, ROIC 13.5% vs -4.4% |
HURC vs AME vs DHR vs MKSI vs A — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HURC vs AME vs DHR vs MKSI vs A — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AME leads in 1 of 6 categories
HURC leads 1 • MKSI leads 1 • DHR leads 0 • A leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AME leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 187.5x HURC's $132M. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to HURC's -10.8%. On growth, MKSI holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $132M | $7.6B | $24.8B | $4.1B | $7.1B |
| EBITDAEarnings before interest/tax | -$9M | $2.3B | $7.2B | $945M | $1.7B |
| Net IncomeAfter-tax profit | -$14M | $1.5B | $3.7B | $327M | $1.3B |
| Free Cash FlowCash after capex | $6M | $1.7B | $5.3B | $401M | $993M |
| Gross MarginGross profit ÷ Revenue | +24.9% | +36.6% | +60.7% | +45.2% | +38.8% |
| Operating MarginEBIT ÷ Revenue | -8.6% | +26.2% | +21.0% | +14.8% | +20.6% |
| Net MarginNet income ÷ Revenue | -10.8% | +20.1% | +14.9% | +8.0% | +18.3% |
| FCF MarginFCF ÷ Revenue | +4.7% | +22.4% | +21.4% | +9.8% | +14.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +11.3% | +3.7% | +15.2% | +7.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +19.4% | +14.5% | +9.8% | +53.2% | -3.6% |
Valuation Metrics
HURC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 26.0x trailing earnings, A trades at a 62% valuation discount to MKSI's 68.8x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.76x vs DHR's 34.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $107M | $53.7B | $124.3B | $20.2B | $33.6B |
| Enterprise ValueMkt cap + debt − cash | $71M | $55.5B | $138.1B | $24.3B | $35.1B |
| Trailing P/EPrice ÷ TTM EPS | -7.12x | 36.64x | 34.85x | 68.83x | 25.96x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.57x | 29.08x | 20.82x | 30.36x | 19.87x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.28x | 34.35x | — | 1.76x |
| EV / EBITDAEnterprise value multiple | — | 29.55x | 18.21x | 26.70x | 19.89x |
| Price / SalesMarket cap ÷ Revenue | 0.60x | 7.26x | 5.06x | 5.15x | 4.83x |
| Price / BookPrice ÷ Book value/share | 0.54x | 5.10x | 2.38x | 7.49x | 5.00x |
| Price / FCFMarket cap ÷ FCF | 6.45x | 32.14x | 23.64x | 40.74x | 29.15x |
Profitability & Efficiency
Evenly matched — HURC and AME and A each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-7 for HURC. HURC carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), AME scores 7/9 vs HURC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -7.1% | +14.4% | +7.1% | +12.2% | +18.7% |
| ROA (TTM)Return on assets | -5.4% | +9.6% | +4.5% | +3.7% | +10.1% |
| ROICReturn on invested capital | -4.4% | +12.1% | +5.9% | +6.5% | +13.5% |
| ROCEReturn on capital employed | -4.7% | +15.0% | +7.0% | +7.2% | +14.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.06x | 0.21x | 0.35x | 1.73x | 0.50x |
| Net DebtTotal debt minus cash | -$37M | $1.8B | $13.8B | $4.0B | $1.6B |
| Cash & Equiv.Liquid assets | $49M | $458M | $4.6B | $675M | $1.8B |
| Total DebtShort + long-term debt | $12M | $2.3B | $18.4B | $4.7B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | -266.46x | 23.34x | 18.13x | 2.84x | 19.53x |
Total Returns (Dividends Reinvested)
MKSI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AME five years ago would be worth $17,454 today (with dividends reinvested), compared to $5,396 for HURC. Over the past 12 months, MKSI leads with a +306.1% total return vs DHR's -8.3%. The 3-year compound annual growth rate (CAGR) favors MKSI at 54.1% vs HURC's -6.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.9% | +12.3% | -23.6% | +78.8% | -13.6% |
| 1-Year ReturnPast 12 months | +11.1% | +38.9% | -8.3% | +306.1% | +11.3% |
| 3-Year ReturnCumulative with dividends | -19.2% | +64.1% | -15.5% | +266.0% | -8.2% |
| 5-Year ReturnCumulative with dividends | -46.0% | +74.5% | -21.1% | +66.5% | -8.0% |
| 10-Year ReturnCumulative with dividends | -36.3% | +423.4% | +219.3% | +750.6% | +205.7% |
| CAGR (3Y)Annualised 3-year return | -6.9% | +18.0% | -5.5% | +54.1% | -2.8% |
Risk & Volatility
Evenly matched — HURC and AME each lead in 1 of 2 comparable metrics.
Risk & Volatility
HURC is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than MKSI's 2.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 96.4% from its 52-week high vs DHR's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.86x | 0.93x | 0.94x | 2.64x | 1.23x |
| 52-Week HighHighest price in past year | $21.46 | $243.18 | $242.80 | $326.83 | $160.27 |
| 52-Week LowLowest price in past year | $13.19 | $168.49 | $172.06 | $71.49 | $104.79 |
| % of 52W HighCurrent price vs 52-week peak | +77.6% | +96.4% | +72.3% | +92.0% | +74.0% |
| RSI (14)Momentum oscillator 0–100 | 55.9 | 63.3 | 33.0 | 65.3 | 52.5 |
| Avg Volume (50D)Average daily shares traded | 20K | 1.2M | 4.2M | 1.2M | 2.0M |
Analyst Outlook
Evenly matched — AME and A each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HURC as "Buy", AME as "Buy", DHR as "Buy", MKSI as "Buy", A as "Buy". Consensus price targets imply 40.6% upside for DHR (target: $247) vs -9.3% for MKSI (target: $273). For income investors, A offers the higher dividend yield at 0.84% vs MKSI's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $245.91 | $247.00 | $272.86 | $166.00 |
| # AnalystsCovering analysts | 1 | 29 | 42 | 29 | 38 |
| Dividend YieldAnnual dividend ÷ price | — | +0.5% | +0.7% | +0.3% | +0.8% |
| Dividend StreakConsecutive years of raises | 0 | 16 | 1 | 0 | 10 |
| Dividend / ShareAnnual DPS | — | $1.23 | $1.23 | $0.87 | $0.99 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% | +2.5% | +0.2% | +1.3% |
AME leads in 1 of 6 categories (Income & Cash Flow). HURC leads in 1 (Valuation Metrics). 3 tied.
HURC vs AME vs DHR vs MKSI vs A: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HURC or AME or DHR or MKSI or A a better buy right now?
For growth investors, MKS Inc.
(MKSI) is the stronger pick with 9. 6% revenue growth year-over-year, versus -4. 3% for Hurco Companies, Inc. (HURC). Agilent Technologies, Inc. (A) offers the better valuation at 26. 0x trailing P/E (19. 9x forward), making it the more compelling value choice. Analysts rate Hurco Companies, Inc. (HURC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HURC or AME or DHR or MKSI or A?
On trailing P/E, Agilent Technologies, Inc.
(A) is the cheapest at 26. 0x versus MKS Inc. at 68. 8x. On forward P/E, Hurco Companies, Inc. is actually cheaper at 7. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 35x versus Danaher Corporation's 34. 35x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — HURC or AME or DHR or MKSI or A?
Over the past 5 years, AMETEK, Inc.
(AME) delivered a total return of +74. 5%, compared to -46. 0% for Hurco Companies, Inc. (HURC). Over 10 years, the gap is even starker: MKSI returned +750. 6% versus HURC's -36. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HURC or AME or DHR or MKSI or A?
By beta (market sensitivity over 5 years), Hurco Companies, Inc.
(HURC) is the lower-risk stock at 0. 86β versus MKS Inc. 's 2. 64β — meaning MKSI is approximately 206% more volatile than HURC relative to the S&P 500. On balance sheet safety, Hurco Companies, Inc. (HURC) carries a lower debt/equity ratio of 6% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HURC or AME or DHR or MKSI or A?
By revenue growth (latest reported year), MKS Inc.
(MKSI) is pulling ahead at 9. 6% versus -4. 3% for Hurco Companies, Inc. (HURC). On earnings-per-share growth, the picture is similar: MKS Inc. grew EPS 55. 5% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, AME leads at 6. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HURC or AME or DHR or MKSI or A?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus -8. 5% for Hurco Companies, Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus -5. 8% for HURC. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HURC or AME or DHR or MKSI or A more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 35x versus Danaher Corporation's 34. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Hurco Companies, Inc. (HURC) trades at 7. 6x forward P/E versus 30. 4x for MKS Inc. — 22. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.
08Which pays a better dividend — HURC or AME or DHR or MKSI or A?
In this comparison, A (0.
8% yield), DHR (0. 7% yield), AME (0. 5% yield), MKSI (0. 3% yield) pay a dividend. HURC does not pay a meaningful dividend and should not be held primarily for income.
09Is HURC or AME or DHR or MKSI or A better for a retirement portfolio?
For long-horizon retirement investors, AMETEK, Inc.
(AME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 0. 5% yield, +423. 4% 10Y return). MKS Inc. (MKSI) carries a higher beta of 2. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AME: +423. 4%, MKSI: +750. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HURC and AME and DHR and MKSI and A?
These companies operate in different sectors (HURC (Industrials) and AME (Industrials) and DHR (Healthcare) and MKSI (Technology) and A (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
AME, DHR, A pay a dividend while HURC, MKSI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.